CELLERANT THERAPEUTICS
Cellerant Therapeutics is a clinical-stage company developing innovative cell- and antibody-based immunotherapies for hematologic malignancies and other blood-related disorders. Cellerant’s Romyelocel-L is a universal cell therapy that does not require HLA matching intended to prevent bacterial and fungal infections during neutropenia. It was founded in 2003 and headquartered in San Carlos, California.
CELLERANT THERAPEUTICS
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2003-01-01
Address:
San Carlos, California, United States
Country:
United States
Website Url:
http://www.cellerant.com
Total Employee:
101+
Status:
Active
Contact:
(650)232-2122
Email Addresses:
[email protected]
Total Funding:
109.77 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Domain Not Resolving Cloudflare Google Google Cloud OpenResty Gravity Forms Google Adsense
Similar Organizations
arGEN-X
arGEN-X offers a platform for antibody lead choice that supports the discovery of human antibody therapeutics.
Cocrystal Pharma
Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics.
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Current Employees Featured
Founder
Investors List
Camelot Collectables
Camelot Collectables investment in Venture Round - Cellerant Therapeutics
Allen & Company
Allen & Company investment in Venture Round - Cellerant Therapeutics
MPM Capital
MPM Capital investment in Series B - Cellerant Therapeutics
Camelot Venture Group
Camelot Venture Group investment in Series B - Cellerant Therapeutics
CX Venture Group
CX Venture Group investment in Series B - Cellerant Therapeutics
Allen & Company
Allen & Company investment in Series B - Cellerant Therapeutics
George Rathmann
George Rathmann investment in Series B - Cellerant Therapeutics
Novel Bioventures
Novel Bioventures investment in Series B - Cellerant Therapeutics
MPM Capital
MPM Capital investment in Series B - Cellerant Therapeutics
Allen & Company
Allen & Company investment in Series A - Cellerant Therapeutics
Official Site Inspections
http://www.cellerant.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 13.248.169.48
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
